He aha ka KPV peptide:ʻO KPV kahi peptide bioactive synthetic i loaʻa mai ka C-terminal ultra-short tripeptide fragment o ka mea maoli. α-Melanocyte-Stimulating Hormone (α-MSH). ʻO ka noiʻi ʻana i nā ʻāpana α-MSH like ʻole i alakaʻi i nā ʻepekema e ʻike i ke kaʻina kikoʻī C-terminal KPV. – ʻo ia nā ʻakika amino hope ʻekolu – nalowale kona hopena hoʻoikaika melanogenesis; hoʻonui nui i nā waiwai anti-inflammatory a me immunomodulatory, akā naʻe, mālama ʻia.
Ke hana nei ʻo KPV ma o nā mīkini non-ergoline; ʻO ka pale ʻana i ka hoʻoulu ʻana a me ka transcription ma hope o nā kumu inflammatory koʻikoʻi ke ʻano o ka hana. ʻO nā cytokines pro-inflammatory he nui no laila ua hoʻopau maikaʻi ʻia i ka hana ʻana a me ka hoʻokuʻu ʻana.
ʻO ka modulation o nā pūnaewele immune kūikawā (lymphocytes, macrophages iwaena o na mea e ae) ʻo ia kekahi mea nui o kona hopena, hoʻololi hou i ke ʻano anti-inflammatory kūloko o ke kino. Hoʻoulu ʻia ka hoʻoponopono inflammatory a hoʻonui ʻia ka hana anti-inflammatory holoʻokoʻa.
Ua hōʻike maopopo ʻia nā hoʻokolohua lapaʻau i ka holomua ma colitis hoʻokolohua; hoemiia ʻūhā mucosal, palekana o pale ʻōpū hana, a ʻo nā ʻano like ʻole o ka hoʻoponopono ʻana i ka pae kikoo/cell he mau hopena hiki ke ana.
ʻO ke kaumaha molekala haʻahaʻa o KPV kekahi pono nui, ka hāʻawi ʻana i ka bioavailability waha maikaʻi loa a me ka mana transdermal absorption kaulana. ʻO ka hoʻokele waha e hiki ai ke pale aku i ka hōʻino ʻia e ka gastrointestinal nā enzymes a hiki i ka opu ʻōnaehana immune mucosal pololei.
Kaʻina
H-Lys-Pro-Val-OH
Helu CAS
67727-97-3
ʻĀpana Molekala
C16H30N4O4
Kaumaha Molekala
342.44
Noi'i o KPV Peptide
1.Hana kūʻē
ʻO kēia ke kikowaena, hana mua o KPV. Ke kuhi nei i ke kumu kumu NF-κB i loko o nā ala hōʻailona inflammatory cellular, ʻO ka pale ʻana i ke kaʻina hana hoʻāla / translocation ka mea e wehewehe ai i kāna hana.
Hoʻopau ʻia ka ʻōlelo a me ke kākau ʻana o nā mea hoʻolaha pro-inflammatory ma ke kumu. Hoʻolaha pū ʻia nā mea anti-inflammatory.
ʻO ka hoʻololi ʻana i ke kaiapuni inflammatory cellular kahi kumu hope loa o nā hana hoʻoponopono ʻelua a KPV.
2.Nā hopena immunomodulatory
Hoʻomaka ka hana immunoregulatory o KPV mai kāna hana anti-inflammatory ikaika. Ke kāohi nei i ka hōʻike o nā genes M1 pro-inflammatory, Hoʻomaʻamaʻa kēia haʻawina i ka wikiwiki i ka reparative M2 phenotype polarization – he mīkini hoʻoponopono koʻikoʻi i loko o ka ʻōnaehana pale.
ʻO ka hoʻomau mau ʻana o ka KPV i nā ʻiole e hōʻike ana i nā pane inflammatory i ka hopena o ka hui hoʻokolohua e hōʻike ana i ka emi ʻana o ka mumū., a i ʻole ka hoʻoholo piha ʻana; physiological functions aligning closely with health controls.
3.Nā hopena hoʻomalu pono i ka maʻi ʻeha o ka ʻōpū (IBD)
Hōʻike ʻia ka waiwai noi kūikawā e KPV i ke olakino ʻōpū.
Hōʻike maopopo ʻia ka hoʻomaikaʻi maikaʻi ʻana o nā kiʻi ʻiole o ka mumū IBD(ʻO ka maʻi ʻāhuehue) nā hōʻailona ma o ka lawelawe waha. pōʻino ʻiʻo ʻōpū, ʻūhā, nā erosions, a ua emi loa ka infiltration cell inflammatory.
ʻO ka hoʻoponopono a me ka hoʻoikaikaʻana i ka pono o ka pale mucosal kekahi o nā hana mua a KPV; hoemiia ka intestinal permeability. Kāohi ʻia ka maʻi bacteria a me kā lākou mau antigens mai ka unuhi ʻana ma waena o ka pale o ka ʻōpū, ma laila e pale ai i ka overactivation o ka ʻōnaehana pale i kona kumu kumu.
Hoola o ka mucosa ʻO ia iho ka hopena pololei o kēia mau hopena pale.
4.Hoʻolaha ʻana i ka hoʻoponopono a me ka hana hou ʻana i ka ʻili
Ma ke kāohi ʻana i ka mumū, Hoʻokumu ʻo KPV i kahi microenvironment cellular i hoʻomaikaʻi ʻia no ka hoʻoponopono ʻana.
Hoʻohana ʻia nā mea anti-inflammatory a me ka hoʻoponopono kelepona. Ua hōʻike nā haʻawina i ka hoʻoponopono hou ʻana a me ka hoʻoponopono hou ʻana o nā ʻāpana epithelial intestinal a me nā cell epidermal ʻili i nā kumuhana i mālama ʻia e KPV..
Hoʻōla ʻeha, a me na mea a pau, he ʻāpana o ka mea hiki iā KPV ke hoʻokō.
COA
HPLC
MS





